Perspective Therapeutics (CATX) Cash from Financing Activities (2010 - 2026)
Perspective Therapeutics recorded quarterly Cash from Financing Activities of $164.4 million in Q1 2026, up 1264438.46% quarter-over-quarter from -$13000.0 in Q4 2025, and up 1548.09% year-over-year from $10.0 million in Q1 2025.
Perspective Therapeutics' Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $164.4 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 1548.09% year-over-year to $164.4 million; the TTM figure through Mar 2026 stood at $164.7 million (up 23.8% YoY), while the FY2025 annual figure was $10.3 million, down 96.44% from the prior year.
- Cash from Financing Activities came in at $164.4 million for Q1 2026 at Perspective Therapeutics, up from -$13000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $166.3 million in Q1 2024 to a low of -$80000.0 in Q1 2023.
- A 5-year average of $31.0 million and a median of $345000.0 in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities soared 208010.0% in 2024 and plunged 103.77% in 2025, its largest moves.
- Perspective Therapeutics' Cash from Financing Activities stood at $28000.0 in 2022, then jumped by 1157.14% to $352000.0 in 2023, then decreased by 1.99% to $345000.0 in 2024, then slumped by 103.77% to -$13000.0 in 2025, then jumped by 1264438.46% to $164.4 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $164.4 million, -$13000.0, and $213000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 164.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 164.36 Mn |
| Mar 31, 2026 | 164.36 Mn |
| Dec 31, 2025 | -13,000.00 |
| Dec 31, 2025 | -13,000.00 |
| Sep 30, 2025 | 213,000.00 |
| Sep 30, 2025 | 213,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Mar 31, 2025 | 9.97 Mn |
| Mar 31, 2025 | 9.97 Mn |
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Sep 30, 2024 | 628,000.00 |
| Sep 30, 2024 | 628,000.00 |
| Jun 30, 2024 | 122.08 Mn |
| Jun 30, 2024 | 122.08 Mn |
| Mar 31, 2024 | 166.33 Mn |
| Mar 31, 2024 | 166.33 Mn |
| Dec 31, 2023 | 352,000.00 |
| Dec 31, 2023 | 352,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 512,000.00 |
| Jun 30, 2023 | 512,000.00 |
| Mar 31, 2023 | -80,000.00 |
| Mar 31, 2023 | -80,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Mar 31, 2021 | 55.98 Mn |
| Mar 31, 2021 | 55.98 Mn |
| Jun 30, 2020 | 874,000.00 |
| Jun 30, 2020 | 874,000.00 |
| Mar 31, 2020 | 131,000.00 |
| Mar 31, 2020 | 131,000.00 |
| Jun 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 13,000.00 |
| Mar 31, 2019 | -9,000.00 |
| Mar 31, 2019 | -9,000.00 |
| Dec 31, 2018 | -124,000.00 |
| Dec 31, 2018 | -124,000.00 |
| Sep 30, 2018 | 7.49 Mn |
| Sep 30, 2018 | 7.49 Mn |
| Jun 30, 2018 | 482,000.00 |
| Jun 30, 2018 | 482,000.00 |
| Dec 31, 2016 | -9,000.00 |
| Dec 31, 2016 | -9,000.00 |
| Mar 31, 2016 | 3,000.00 |
| Mar 31, 2016 | 3,000.00 |
| Dec 31, 2015 | -11,000.00 |
| Dec 31, 2015 | -11,000.00 |
| Sep 30, 2015 | 47,000.00 |
| Sep 30, 2015 | 47,000.00 |
| Jun 30, 2015 | 79,569.00 |
| Jun 30, 2015 | 79,569.00 |
| Mar 31, 2015 | 378.00 |
| Mar 31, 2015 | 378.00 |
| Jun 30, 2014 | 385,806.00 |
| Jun 30, 2014 | 385,806.00 |
| Mar 31, 2014 | 19.80 Mn |
| Mar 31, 2014 | 19.80 Mn |
| Dec 31, 2013 | -12,228.00 |
| Dec 31, 2013 | -12,228.00 |
| Sep 30, 2013 | 3.28 Mn |
| Sep 30, 2013 | 3.28 Mn |
| Jun 30, 2013 | 1,820.00 |
| Jun 30, 2013 | 1,820.00 |
| Dec 31, 2012 | -7,035.00 |
| Dec 31, 2012 | -7,035.00 |
| Sep 30, 2012 | 3.30 Mn |
| Sep 30, 2012 | 3.30 Mn |
| Jun 30, 2012 | 798,298.00 |
| Jun 30, 2012 | 798,298.00 |
| Mar 31, 2012 | -5,216.00 |
| Mar 31, 2012 | -5,216.00 |
| Dec 31, 2011 | 2.27 Mn |
| Dec 31, 2011 | 2.27 Mn |
| Sep 30, 2011 | 40,244.00 |
| Sep 30, 2011 | 40,244.00 |
| Jun 30, 2011 | 610,640.00 |
| Jun 30, 2011 | 610,640.00 |
| Mar 31, 2011 | -13,001.00 |
| Mar 31, 2011 | -13,001.00 |
| Dec 31, 2010 | 2.42 Mn |
| Dec 31, 2010 | 2.42 Mn |
| Sep 30, 2010 | -11,919.00 |
| Sep 30, 2010 | -11,919.00 |